CVI Holdings’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

CVI Holdings’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-187,425	Closed	-$22K	–	796
2022 Q3	$22K	Hold	187,425	–	–	﹤0.01%	543
2022 Q2	$20K	Hold	187,425	–	–	﹤0.01%	640
2022 Q1	$32K	Buy	+187,425	New	+$38K	﹤0.01%	698

CVI Holdings's ZVSAW Position: Q4 2022 in Review

CVI Holdings sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 187,425 shares — an estimated $22K sold.

CVI Holdings first reported a position in ZVSAW in Q1 2022 and held it in 3 quarters. The position peaked at $32K in Q1 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

CVI Holdings reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
CVI Holdings sold 187,425 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $22K.
CVI Holdings first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q1 2022 and held it in 3 quarters.
CVI Holdings's ZyVersa Therapeutics, Inc. Warrants position peaked at $32K in Q1 2022.
1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on CVI Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.